Dr. Ceren Gonen Korkmaz

Research Scientist
University of Oslo, Norway

Highest Degree
Ph.D. in Molecular Pharmacology from University of Oslo, Norway

My URL
https://livedna.org/90.15279

Share this Profile

Area of Interest:

Molecular Sciences
Molecular Pharmacology
Molecular Biosciences
Cell Biology
Pathology

Selected Publications

  1. Ogut, D., B. Reel, C.G. Korkmaz, M.Z. Arun, S.C. Micili and B.U. Ergur, 2016. Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells. Folia Histochemica Cytobiologica, 54: 171-180.
    CrossRef  |  Direct Link  |  

  2. Gonen-Korkmaz, C., G. Sevin, G. Gokce, M.Z. Arun and G. Yetik-Anacak et al., 2016. Role of Six Trans Membrane Protein of Prostate (STAMP) proteins in prostate cancer-relation with survival genes. J. Cell Signal., Vol. 1. .
    Direct Link  |  

  3. Reel, B., C.G. Korkmaz, M.Z. Arun, G. Yildirim and D. Ogut et al., 2015. The regulation of matrix metalloproteinase expression and the role of discoidin domain receptor 1/2 signalling in zoledronate-treated PC3 cells. J. Cancer, 6: 1020-1029.
    CrossRef  |  Direct Link  |  

  4. Hamid, S.M., S. Cicek, S. Karamil, M.B. Ozturk and B. Debelec-Butuner et al., 2014. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate. Mol. Cell. Endocrinol., 383: 38-47.
    CrossRef  |  Direct Link  |  

  5. Gonen-Korkmaz, C., G. Sevin, G. Gokce, M.Z. Arun and G. Yildirim et al., 2014. Analysis of tumor necrosis factor α-induced and nuclear factor κB-silenced LNCaP prostate cancer cells by RT-qPCR. Exp. Therapeut. Med., 8: 1695-1700.
    CrossRef  |  Direct Link  |  

  6. Erbaykent-Tepedelen, B., S. Karamil, C. Gonen-Korkmaz and K.S. Korkmaz, 2014. DNA Damage Response (DDR) via NKX3.1 expression in prostate cells. J. Steroid Biochem. Mol. Biol., 141: 26-36.
    CrossRef  |  Direct Link  |  

  7. Debelec-Butuner, B., C. Alapinar, N. Ertunc, C. Gonen-Korkmaz, K. Yorukoglu and K.S. Korkmaz, 2014. TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells. PLoS ONE, Vol. 9. 10.1371/journal.pone.0109868.
    CrossRef  |  Direct Link  |  

  8. Debelec-Butuner, B., C. Alapinar, L. Varisli, B. Erbaykent-Tepedelen, S.M. Hamid, C. Gonen-Korkmaz and K.S. Korkmaz, 2014. Inflammation-mediated abrogation of androgen signaling: An in vitro model of prostate cell inflammation. Mol. Carcinogen., 53: 85-97.
    CrossRef  |  Direct Link  |  

  9. Varisli, L., C. Gonen-Korkmaz, H.M. Syed, N. Bogurcu, B. Debelec-Butuner, B. Erbaykent-Tepedelen and K.S. Korkmaz, 2012. Androgen regulated HN1 leads proteosomal degradation of Androgen Receptor (AR) and negatively influences AR mediated transactivation in prostate cells. Mol. Cell. Endocrinol., 350: 107-117.
    CrossRef  |  Direct Link  |  

  10. Varisli, L., C. Gonen-Korkmaz, B. Debelec-Butuner, B. Erbaykent-Tepedelen and H.S. Muhammed et al., 2011. Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its knockdown results in deregulated G2/M transition in prostate cells. DNA Cell Biol., 30: 419-429.
    CrossRef  |  Direct Link  |  

  11. Erbaykent-Tepedelen, B., B. Ozmen, L. Varisli, C. Gonen-Korkmaz and B. Debelec-Butuner et al., 2011. NKX3.1 contributes to S phase entry and regulates DNA Damage Response (DDR) in prostate cancer cell lines. Biochem. Biophys. Res. Commun., 414: 123-128.
    CrossRef  |  Direct Link  |  

  12. Korkmaz, C.G., K.S. Korkmaz, P. Kurys, C. Elbi and L. Wang et al., 2005. Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene, 24: 4934-4945.
    CrossRef  |  Direct Link  |  

  13. Korkmaz, C.G., K.S. Korkmaz, J. Manola, Z. Xi and B. Risberg et al., 2004. Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis. J. Urol., 172: 1134-1139.
    Direct Link  |  

  14. Korkmaz, C.G., K. Fronsdal, Y. Zhang, P.I. Lorenzo and F. Saatcioglu, 2004. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation-rescue of transcriptionally compromised mutants. J. Endocrinol., 182: 377-389.
    CrossRef  |  Direct Link  |  

  15. Skotheim, R.I., K.S. Korkmaz, T.I. Klokk, V.M. Abeler and C.G. Korkmaz et al., 2003. NKX3.1 expression is lost in testicular germ cell tumors. Am. J. Pathol., 163: 2149-2154.
    CrossRef  |  Direct Link  |  

  16. Korkmaz, K.S., C. Elbi, C.G. Korkmaz, M. Loda, G.L. Hager and F. Saatcioglu, 2002. Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J. Biol. Chem., 277: 36689-36696.
    CrossRef  |  Direct Link  |  

  17. Engedal, N., C.G. Korkmaz and F. Saatcioglu, 2002. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Oncogene, 21: 1017-1027.
    CrossRef  |  PubMed  |  Direct Link  |  

  18. Korkmaz, K.S., C.G. Korkmaz, T.G. Pretlow and F. Saatcioglu, 2001. Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: Intracellular localization, alternative cDNA forms and regulation by multiple hormones. DNA Cell Biol., 20: 435-445.
    CrossRef  |  Direct Link  |  

  19. Korkmaz, K.S., C.G. Korkmaz, E. Ragnhildstveit, T.G. Pretlow and F. Saatcioglu, 2000. An efficient procedure for cloning hormone-responsive genes from a specific tissue. DNA Cell Biol., 19: 499-506.
    CrossRef  |  Direct Link  |  

  20. Korkmaz, K.S., C.G. Korkmaz, E. Ragnhildstveit, S. Kizildag, T.G. Pretlow and F. Saatcioglu, 2000. Full-length cDNA sequence and genomic organization of human NKX3A-alternative forms and regulation by both androgens and estrogens. Gene, 260: 25-36.
    CrossRef  |  Direct Link  |  

  21. Apaydin, S., C. Gonen and H. Guven, 1998. The probable role of nitric oxide on the relaxations obtained by caffeine and aminophylline in rat uterus. Pharmacol. Res., 38: 387-392.
    CrossRef  |  Direct Link  |  
Member since April, 2017